期刊
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
卷 39, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s13046-019-1517-0
关键词
Hypoxia; HIF; Oxygen sensing; VHL; Angiogenesis; VEGF; Cancer; Metastasis
类别
资金
- Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 2015 16742, IG 2015 17459, IG 2016 18560]
- Fondi Ateneo
- Ministry of Health (Ricerca Finalizzata) [RF-2016-02361048]
Low oxygen condition (hypoxia) is considered a hallmark of rapidly growing solid tumors. The presence of hypoxia renders tumor cells resistant to conventional chemo- and radio-therapy selecting a more malignant and invasive phenotype, and playing a negative role in patient prognosis. This commentary wishes to recognize the 2019 Nobel Prize in Medicine awarded to three physicians-scientists, Prof. William G. Kaelin Jr., Prof. Sir Peter J. Ratcliffe, and Prof. Gregg L. Semenza, for their discovery of the mechanisms mediating cell ability to sense and adapt to changes in oxygen availability. Their studies established the basis for our understanding of the role of hypoxia in a variety of diseases, including anemia, renal failure, cardiovascular disease, metabolic diseases, and cancer, paving the way for new promising therapeutic strategies through the development of drugs that can either activate or block the oxygen-sensing machinery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据